The company’s closure follows the FDA’s recent advisory, which urged consumers to discard Cue Health’s COVID-19 test kits due to potential false results. Cue Health said May 16 that it stopped selling its COVID-19 tests.
This is Cue Health’s second round of layoffs. On May 3, Cue Health laid off 230 employees, equating to 49% of its workforce. Cue Health said the move was made in a bid to lower its cost framework and enhance its operational effectiveness.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.